Renal function in patients with β-thalassaemia major: a long-term follow-up study

Little information is available about the kidneys involvement in patients with -thalassaemia major (TM). In particular, there are no studies reporting the outcome of renal function over time. In this retrospective study, we evaluated the changes in estimated glomerular filtration rate (eGFR) in 81 adult patients with TM followed for 10 years. Only patients who had an eGFR of 90 mL/min/1.73 m(2) at presentation were admitted to the study. All patients were regularly followed for at least 10 years. At 10 years, 66 patients showed a mild decline in eGFR that remained, however, within a normal range (from 119.9 to 113.6 mL/min/1.73 m(2), P 0.636). In the remaining 15 patients (18.5), eGFR decreased to 90 mL/min (from 98.1 to 78.2 mL/min/1.73 m(2); P 0.004). The repeated-measures models showed that the decline in eGFR over time was significantly higher (P 0.0068) in patients with baseline phosphaturia 1000 mg/24 h (P 0.0068), while eGFR tended to decline more rapidly in patients with baseline uricuria 700 mg/24 h than in those with lower uricuria (P 0.0783). Univariate Coxs proportional regression models showed that abnormal levels of calcaemia were associated with the risk of kidney damage [hazard ratio (HR) 0.30, 95 confidence interval 0.090.97 for calcaemia 8.410.2 mg/dL versus HR not estimable for calcaemia 8.4 or 10.2 mg/dL]. In most adults with TM, the eGFR tends to remain within a normal range after 10 years. However, patients with elevated phosphaturia, elevated uricuria and/or abnormal levels of calcaemia show a significant decline in eGFR over time, suggesting that tubular damage acquired in childhood caused by either TM or its treatment may eventually result in abnormal eGFR. Further studies in a larger cohort of TM patients are needed to further elucidate the long-term impact of TM on renal function.